BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8227326)

  • 1. A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome.
    Harel Y; Silva M; Giroir B; Weinberg A; Cleary TB; Beutler B
    J Clin Invest; 1993 Nov; 92(5):2110-6. PubMed ID: 8227326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
    Louise CB; Obrig TG
    Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha production induced by viruses and by lipopolysaccharides in macrophages: similarities and differences.
    Willeaume V; Kruys V; Mijatovic T; Huez G
    J Inflamm; 1995-1996; 46(1):1-12. PubMed ID: 8832967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shiga toxin-1 regulation of cytokine production by human proximal tubule cells.
    Hughes AK; Stricklett PK; Kohan DE
    Kidney Int; 1998 Oct; 54(4):1093-106. PubMed ID: 9767525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.
    Giroir BP; Johnson JH; Brown T; Allen GL; Beutler B
    J Clin Invest; 1992 Sep; 90(3):693-8. PubMed ID: 1522226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies.
    Keir LS; Marks SD; Kim JJ
    Drug Des Devel Ther; 2012; 6():195-208. PubMed ID: 22888220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of tumor necrosis factor promoter responses to ultraviolet light.
    Bazzoni F; Kruys V; Shakhov A; Jongeneel CV; Beutler B
    J Clin Invest; 1994 Jan; 93(1):56-62. PubMed ID: 8282822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biosynthesis of tumor necrosis factor during pregnancy: studies with a CAT reporter transgene and TNF inhibitors.
    Giroir BP; Peppel K; Silva M; Beutler B
    Eur Cytokine Netw; 1992; 3(6):533-8. PubMed ID: 1296801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro.
    Louise CB; Obrig TG
    Infect Immun; 1991 Nov; 59(11):4173-9. PubMed ID: 1937774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of TNF-alpha, Shiga toxin and calcium ionophore on Weibel-Palade body content of endothelial cells: possible implications for the hemolytic uremic syndrome.
    Kaye SA; Obrig TG
    Thromb Res; 1995 Aug; 79(4):415-21. PubMed ID: 7482445
    [No Abstract]   [Full Text] [Related]  

  • 11. Endothelial heterogeneity in Shiga toxin receptors and responses.
    Obrig TG; Louise CB; Lingwood CA; Boyd B; Barley-Maloney L; Daniel TO
    J Biol Chem; 1993 Jul; 268(21):15484-8. PubMed ID: 8340376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1.
    Taylor FB; Tesh VL; DeBault L; Li A; Chang AC; Kosanke SD; Pysher TJ; Siegler RL
    Am J Pathol; 1999 Apr; 154(4):1285-99. PubMed ID: 10233866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral iron compounds sensitize mice to injury-initiated TNF-alpha mRNA production and TNF-alpha release.
    Zager RA; Johnson AC; Hanson SY; Lund S
    Am J Physiol Renal Physiol; 2005 Feb; 288(2):F290-7. PubMed ID: 15494544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic proximal tubular injury primes mice to endotoxin-induced TNF-alpha generation and systemic release.
    Zager RA; Johnson AC; Hanson SY; Lund S
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F289-97. PubMed ID: 15798091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro.
    Louise CB; Obrig TG
    Infect Immun; 1992 Apr; 60(4):1536-43. PubMed ID: 1548077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct.
    Radolf JD; Norgard MV; Brandt ME; Isaacs RD; Thompson PA; Beutler B
    J Immunol; 1991 Sep; 147(6):1968-74. PubMed ID: 1890308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of nitric oxide production in mouse macrophages by Shiga toxin.
    Yuhas Y; Kaminsky E; Mor M; Ashkenazi S
    J Med Microbiol; 1996 Aug; 45(2):97-102. PubMed ID: 8683558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The proximal promoter region is essential for lipopolysaccharide induction and cyclic AMP inhibition of mouse tumor necrosis factor-alpha.
    O'Donnell PM; Taffet SM
    J Interferon Cytokine Res; 2002 May; 22(5):539-48. PubMed ID: 12060492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide-induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha.
    Barsig J; Küsters S; Vogt K; Volk HD; Tiegs G; Wendel A
    Eur J Immunol; 1995 Oct; 25(10):2888-93. PubMed ID: 7589088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amrinone on tumor necrosis factor production in endotoxic shock.
    Giroir BP; Beutler B
    Circ Shock; 1992 Mar; 36(3):200-7. PubMed ID: 1611705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.